CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative b ...
Phase 2
Philadelphia, Pennsylvania, United States and 9 other locations
The purpose of this study is to determine if a combination of two drugs ipatasertib and atezolizumab works as a treatment for residual cancer...
Phase 2
Philadelphia, Pennsylvania, United States and 8 other locations
the feasibility of 1 year of adjuvant enzalutamide, an androgen receptor (AR) antagonist for the treatment of patients with early stage, AR(+) triple...
Phase 2
Allentown, Pennsylvania, United States and 11 other locations
avelumab with sacituzumab govitecan works in treating patients with triple negative breast cancer that is stage I...
Phase 2
Philadelphia, Pennsylvania, United States and 11 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Philadelphia, Pennsylvania, United States and 166 other locations
This study will assess the efficacy and safety of Niraparib in participants with either tumor mutation in the BRCA gene (tBRCAmut) HER2- breast...
Phase 3
Philadelphia, Pennsylvania, United States and 199 other locations
previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors...
Phase 3
Philadelphia, Pennsylvania, United States and 516 other locations
with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors...
Phase 3
Philadelphia, Pennsylvania, United States and 505 other locations
CAR T-cell therapy, in patients with ROR1+ relapsed or refractory triple negative breast cancer (TNBC), non-small...
Phase 1
Philadelphia, Pennsylvania, United States and 17 other locations
vs placebo as adjuvant therapy in participants who have triple negative breast cancer (TNBC).After a screening ph...
Phase 3
Newark, Delaware, United States and 192 other locations
Clinical trials
Research sites
Resources
Legal